In this population-based study, we examined the risk of nontuberculous mycobacterial disease associated with immune checkpoint inhibitors among people with cancer. Using a nested case-control design, we identified 184 cases and 714 matched controls; there was no significant association on conditional logistic regression (adjusted odds ratio, 0.51 [95% confidence interval, .17-1.50]; P = .22).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/cid/ciae626 | DOI Listing |
Publication Analysis
Top Keywords
associated immune
8
immune checkpoint
8
checkpoint inhibitors
8
population-based analysis
4
analysis risk
4
risk mycobacterial
4
mycobacterial infections
4
infections associated
4
inhibitors population-based
4
population-based study
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!